Stand up to beat diabetes: new study tests desk hack
NCT ID NCT05585190
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a sit-stand desk at work can improve insulin sensitivity and reduce diabetes risk in 198 overweight, sedentary adults with prediabetes or other risk factors. Participants are randomly assigned to stand 2 or 3 hours per day at a sit-stand desk, or to a control group, for 6 months. Researchers will measure changes in insulin resistance, blood sugar, and other health markers.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Sit-stand desk
- What this could lead to
- If it works, this could point toward a simple workplace change to help prevent or delay type 2 diabetes in at-risk adults.
- What could go wrong
- This is a relatively small, early-phase trial (198 participants) testing a behavioral intervention, so results may not apply broadly. The effect may be modest or require long-term adherence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 198 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2023
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 79 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Overweight or obese (body mass index of 25 kg/m2 or higher) 2. Employees with "sedentary" jobs, defined as spending at least 75% of their (8 hours or more) workday sitting at a desk (at home or in an office) 3. Defined as "at-risk" for diabetes, defined as either: 1. Prediabetes (HbA1c of 5.7% to 6.4%) or a fasting glucose of 100 to 125 mg/dL 2. Having one or more additional risk factors: (beyond BMI\>25) * Age 45 years or older * Family history of diabetes mellitus in a first-degree relative * Physical inactivity (no structured exercise activity) * History of gestational diabetes, hypertension, or dyslipidemia * African American, Alaska Native, American Indian, Asian American, Hispanic/Latino, Native Hawaiian, or Pacific Islander ethnicity Exclusion Criteria: 1. Established cardiovascular disease (myocardial infarction, coronary stent, coronary artery bypass grafting, cardiac transplant, or angina) 2. Established congestive heart failure or cardiomyopathy 3. Established peripheral vascular disease 4. Established diabetes (HbA1c ≥ 6.5% or on diabetes medications or insulin) 5. Chronic musculoskeletal disorders involving the lower extremities, such as arthritis of the knees or hips, or regular use of ambulatory assist devices such as a walker or cane 6. Neuropathy of any etiology 7. Positional syncope or history of orthostasis 8. Less than 4 days/week at any single office (or work-from-home) location. 9. Current use of a standing desk for work 10. Tobacco use within the previous 12 months 11. Current illicit drug use or excessive alcohol use (defined as more than 14 drinks/week for women, more than 28 drinks/week for men) 12. Steroid use ≥21 days/year 13. Fasting triglyceride level ≥ 500 mg/dL 14. Thyroid disease 15. Uncontrolled or untreated hypertension(\>150/90 mm Hg) 16. Pregnant or lactating (or plans to become pregnant in the next 6 months) 17. LDL cholesterol ≥ 190mg/dL 18. Currently enrolled or plans to diet or join a weight loss program over the next 6 months. 19. Non-English speaker
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Metabolic syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?
- Can an AI chatbot coach people away from type 2 diabetes?